New Alzheimer's Drug Leqembi Gains Accelerated Approval From The FDA

The FDA has just approved new medication for Alzheimer's patients. Leqembi (lecanemab-irmb), a medication for the treatment of Alzheimer's disease, has just received approval from the US Food and Drug Administration through the Accelerated Approval pathway.

Related Keywords

United States ,Americans ,Billy Dunn ,Drug Administration ,Office Of Neuroscience ,Accelerated Approval ,Alzheimers Disease ,Alzheimer S ,Lzheimers Medications ,